期刊文献+

SDF—1α和c—MYC蛋白调控速激肽受体-1截短型mRNA表达的研究 被引量:1

The study on SDF-1α and c-MYC protein regulate tachykinin receptor 1-trucated mRNA expression
原文传递
导出
摘要 目的 观察基质细胞衍生因子1α(stromal cell derived factor 1α,SDF-1α)、c-MYC蛋白对速激肽受体-1截短型(tachykinin receptor 1 trucated,TACRI-Tr)转录水平的影响.方法 构建c-myc基因shRNA表达载体;用小干扰RNA方法沉默乳腺癌细胞MCF-7的c-myc基因,分成c-myc+细胞组和c-myc-细胞组,相关实验组加SDF-1α细胞因子中和抗体,用实时定量PCR检测TYACR1-Tr mRNA表达水平.结果 c-myc基因shRNA表达载体构建成功;在正常培养条件下,c-myc-细胞组的TACR1-Tr转录水平低于c-myc+细胞组(P〈0.05);加了SDF-1α中和抗体后,c-myc-组TACR1-Tr的mRNA表达水平高于c-myc+组(P〈0.05).结论 MCF-7细胞在正常培养条件下,c-MYC蛋白可以反式激活TACRI-Tr的转录;但加入SDF-1α因子中和抗体后,c-MYC蛋白失去了这种激活作用. Objective To investigate how SDF-1α and c-MYC protein regulates TACRl-Tr expression. Methods c-myc shRNA vector was constructed, small interfering RNA was employed for silencing c-myc gene in MCF-7 breast cancer cell. SDF-1α neutralized antibody was used in c-myc+ cell group and c-myc- cell group, while other c-myc+ cell group and c-myc- cells group were cultured under normal condition. The mRNA level of TACRl-Tr was determined by real-time PCR. Results c-myc shRNA vector was constructed successfully, in the normal presence of SDF-la, the level of TACRl-Tr mRNA in c-myc- cell group were lower than that in c-myc+ cell group( P 〈 0.05). But in the presence of SDF-la neutralized antibody, TACRl-Tr mRNA level of c-myc- cell group was higher than that of c-myc+ cell group(P 〈 0.05). Conclusion In the normal culture condition, c-MYC protein may transactivate TACRl-Tr transcription in MCF-7 cell, in the presence of SDF-1α neutral antibody, c-MYC protein lost the activity of transactivating for TACRl-Tr transciption.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第3期241-244,共4页 Chinese Journal of Microbiology and Immunology
基金 基金项目:国家自然科学基金资助项目(30670802)
关键词 基质细胞衍生因子1Α 速激肽受体-1 shRNA c—myc基因 Stromal cell derived factor 1α Tachykinin receptor 1 shRNA c-myc gene
  • 相关文献

参考文献20

  • 1Pennefather JN,Lecci A,Candenas ML,et al.Tachykinins and tachyltinin receptors; a growing family.Life Sci,2004,74(12):1445-1463. 被引量:1
  • 2McGregor CP,Hartel R,Haberberger R,et al.Preprotachykinin-A gene expression occurs transiently in the developing rat endocrine pancreas and can be regulated in RINm5F cells.Endocrinology,1995,136(6):2538-2546. 被引量:1
  • 3Cremins JD,Michel J,Farah JM,et al.Characterization of substance P-like immunoreactivity and tachykinin-encoding mRNAs in rat medullary thyroid carcinoma cell lines.J Neurochem,1992,58(3):817-825. 被引量:1
  • 4Hennig IM,Laissue JA,Horisberger U,et al.Substance-P receptors in human primary neoplasms:tumoral and vascular localiza-tion.Int J Cancer,1995,61(6):786-792. 被引量:1
  • 5Rameshwar P,Poddar A,Gasc6n P.Hematopoietic regulation mediated by interactions among the neurokinins and cytokines.Leuk Lymphoma,1997,28(1-2):1-10. 被引量:1
  • 6Bost KL,Breeding SA,Pascual DW.Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.Reg Immunol,1992,4(2):105-112. 被引量:1
  • 7Patel HJ,Ramkissoon SH,Patel PS,et al.Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides.Proc Natl Acad Sci USA,2005,102(48):17436-17441. 被引量:1
  • 8Singh D,Joshi DD,Hameed M,et al.Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells:implications for bone marrow metastasis.Proc Natl Acad Sci USA,2000,97(1):388-393. 被引量:1
  • 9Bandari PS,Qian J,Oh HS,et al.Crosstalk between neurokinin receptors is relevant to hematopoietic regulation:cloning and characterization of neurokinin-2 promoter.J Neuroinununol,2003,138(1-2):65-75. 被引量:1
  • 10Oh HS,Moharita A,Potian JG,et al.Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.Cancer Res,2004,64(17):6327-6336. 被引量:1

同被引文献18

  • 1Esteban F,Mufioz M,Gonzfilez-Moles MA, et al. A role for sub-stance P in cancer promotion and progression : a mechanism tocounteract intracellular death signals following oncogene activationor DNA damage[ J]. Cancer Metastasis Rev,2006 , 25 (1) : 137-145. 被引量:1
  • 2Mufioz M,Rosso M,Covefias H. A new frontier in the treatment ofcancer: NK-1 receptor antagonists [ J]. Curr Med Chem, 2010,17(6) : 504-516. 被引量:1
  • 3Gillespie E, Leeman SE, Watts LA,et al. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients withcolitis-associated cancer[ J]. Proc Natl Acad Sci USA, 2011,108(42) : 17420-17425. 被引量:1
  • 4Lai JP, Ho WZ, Kilpatrick LE, et al. Full-length and truncatedneurokinin-1 receptor expression and function during monocyte/macrophage differentiation[ J]. Proc Natl Acad Sci USA, 2006,103(20) : 7771-7776. 被引量:1
  • 5Zhou Y, Zhao L,Xiong T, et al. Roles of full-length and trun-cated neurokinin-1 receptors on tumor progression and distant me-tastasis in human breast cancer [ J ]. Breast Cancer Res Treat,2013, 140(1) : 49-61. 被引量:1
  • 6Volm M, Mattem J, Koomagi R. Angiostatin expression in non-small cell lung cancer[ J]. Clin Cancer Res, 2000, 6(8) ; 3236-3240. 被引量:1
  • 7Hammond ME, Hayes DF, Wolff AC, et al. American society ofclinical oncology/college of american pathologists guideline recom-mendations for immunohistochemical testing of estrogen and proges-terone receptors in breast cancer[ J]. J Oncol Pract, 2010, 6(4):195-197. 被引量:1
  • 8Rosso M, Robles-Frias MJ, Coveftas R, et al. The NK-1 receptoris expressed in human primary gastric and colon adenocarcinomasand is involved in the antitumor action of L-733 ,060 and the mito-genic action of substance P on human gastrointestinal cancer celllines[J]. Tumour Biol, 2008, 29(4) : 245-254. 被引量:1
  • 9Brener S, Gonz6lez-Moles MA, Tostes D, et al. A role for thesubstance P/NK-1 receptor complex in cell proliferation in oralsquamous cell carcinoma [ J]. Anticancer Res,2009,29 ( 6 ):2323-2329. 被引量:1
  • 10Ho WZ, Lai JP, Zhu XH, et al. Human monocytes and macro-phages express substance P and neurokinin-1 receptor[ J]. J Im-munol, 1997, 159(11) : 5654-5660. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部